{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:38:41Z","timestamp":1776494321941,"version":"3.51.2"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10384-025-01283-3","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T07:33:46Z","timestamp":1758872026000},"page":"238-244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of corneal and anterior segment parameters in pediatric phenylketonuria"],"prefix":"10.1007","volume":"70","author":[{"given":"Sevim Ay\u00e7a","family":"Seyyar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gizem G\u00fcrbostan","family":"Soysal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duhan","family":"Hopurcuo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"1283_CR1","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","volume":"376","author":"N Blau","year":"2010","unstructured":"Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet. 2010;376:1417\u201327.","journal-title":"Lancet"},{"key":"1283_CR2","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s10545-007-0644-5","volume":"30","author":"JG Loeber","year":"2007","unstructured":"Loeber JG. Neonatal screening in Europe; the situation in 2004. J Inherit Metab Dis. 2007;30:430\u20138.","journal-title":"J Inherit Metab Dis"},{"key":"1283_CR3","first-page":"35","volume":"20","author":"M Velema","year":"2015","unstructured":"Velema M, Boot E, Engelen M, Hollak C. Parkinsonism in phenylketonuria: a consequence of dopamine depletion? JIMD Rep. 2015;20:35\u20138.","journal-title":"JIMD Rep."},{"key":"1283_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ajhg.2017.01.002","volume":"100","author":"Y Anikster","year":"2017","unstructured":"Anikster Y, Haack TB, Vilboux T, Pode-Shakked B, Th\u00f6ny B, Shen N, et al. Biallelic mutations in DNAJC12 cause hyperphenylalaninemia, dystonia, and intellectual disability. Am J Hum Genet. 2017;100:257\u201366.","journal-title":"Am J Hum Genet"},{"key":"1283_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/07315724.2001.10719016","volume":"20","author":"GL Arnold","year":"2001","unstructured":"Arnold GL, Kirby R, Preston C, Blakely E. Iron, and protein sufficiency and red cell indices in phenylketonuria. J Am Coll Nutr. 2001;20:65\u201370.","journal-title":"J Am Coll Nutr"},{"key":"1283_CR6","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1542\/peds.32.3.338","volume":"32","author":"R Guthrie","year":"1963","unstructured":"Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963;32:338\u201343.","journal-title":"Pediatrics"},{"key":"1283_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13023-020-01407-7","volume":"15","author":"S Hopf","year":"2020","unstructured":"Hopf S. Saccadic reaction time and ocular findings in phenylketonuria. Orphanet J Rare Dis. 2020;15:124.","journal-title":"Orphanet J Rare Dis"},{"key":"1283_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1055\/s-2008-1052440","volume":"19","author":"R Korinthenberg","year":"1988","unstructured":"Korinthenberg R, Ullrich K, F\u00fcllenkemper F. Evoked potentials and electroencephalography in adolescents with phenylketonuria. Neuropediatrics. 1988;19:175\u20138.","journal-title":"Neuropediatrics"},{"key":"1283_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/jnnp.59.3.260","volume":"59","author":"SJ Jones","year":"1995","unstructured":"Jones SJ. Visual evoked potentials in phenylketonuria: association with brain MRI, dietary state, and IQ. J Neurol Neurosurg Psychiatry. 1995;59:260\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1283_CR10","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1001\/archopht.1983.01040020238016","volume":"101","author":"J Zwaan","year":"1983","unstructured":"Zwaan J. Eye findings in patients with phenylketonuria. Arch Ophthalmol. 1983;101:1236\u20137.","journal-title":"Arch Ophthalmol"},{"key":"1283_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4274\/tjo.10179","volume":"48","author":"A\u015e Do\u011fan","year":"2018","unstructured":"Do\u011fan A\u015e, G\u00fcrdal C, K\u00f6yl\u00fc MT. Does dry eye affect repeatability of corneal topography measurements? Turk J Ophthalmol. 2018;48:57\u201360.","journal-title":"Turk J Ophthalmol"},{"key":"1283_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12886-025-03905-3","volume":"25","author":"J Yu","year":"2025","unstructured":"Yu J, Xu Y, Wang X, Qian Y. Tomographic characteristics of thick corneas. BMC Ophthalmol. 2025;25:69.","journal-title":"BMC Ophthalmol"},{"key":"1283_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3928\/0191-3913-19850301-12","volume":"22","author":"L Cotticelli","year":"1985","unstructured":"Cotticelli L, Costagliola C, Rinaldi E, DiMeo A, Sartorio R, Vajro P, et al. Ophthalmological findings of phenylketonuria: a survey of 14 cases. J Pediatr Ophthalmol Strabismus. 1985;22:78\u20139.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"1283_CR14","unstructured":"Duke-Elder S, Leigh AG: Diseases of the outer eye, in Duke-Elder S (ed): System of Ophthalmology. St Louis, CV Mosby Co, 1965, p 1068."},{"key":"1283_CR15","first-page":"273","volume-title":"Pediatric ophthalmology","author":"PR Laibson","year":"1975","unstructured":"Laibson PR, Waring GO. Diseases of the cornea. In: Harley RD, editor. Pediatric ophthalmology. Philadelphia: WB Saunders Co; 1975. p. 273\u2013325."},{"key":"1283_CR16","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/BF02072629","volume":"150","author":"DB Pitt","year":"1991","unstructured":"Pitt DB, O\u2019Day J. Phenylketonuria does not cause cataracts. Eur J Pediatr. 1991;150:661\u20134.","journal-title":"Eur J Pediatr"},{"key":"1283_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1023\/B:DOOP.0000019487.88486.0a","volume":"108","author":"P Witkovsky","year":"2004","unstructured":"Witkovsky P. Dopamine and retinal function. Doc Ophthalmol. 2004;108:17\u201340.","journal-title":"Doc Ophthalmol"},{"key":"1283_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.exer.2013.02.007","volume":"114","author":"M Feldkaemper","year":"2013","unstructured":"Feldkaemper M, Schaeffel F. An updated view on the role of dopamine in myopia. Exp Eye Res. 2013;114:106\u201319.","journal-title":"Exp Eye Res"},{"key":"1283_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.preteyeres.2017.06.003","volume":"61","author":"X Zhou","year":"2017","unstructured":"Zhou X, Pardue MT, Iuvone PM, Qu J. Dopamine signaling and myopia development: what are the key challenges. Prog Retin Eye Res. 2017;61:60\u201371.","journal-title":"Prog Retin Eye Res"},{"key":"1283_CR20","volume":"25","author":"C Serfozo","year":"2020","unstructured":"Serfozo C, Barta AG, Horvath E, Sumanszki C, Csakany B, Resch M, et al. Altered visual functions, macular ganglion cell and papillary retinal nerve fiber layer thickness in early-treated adult PKU patients. Mol Genet Metab Rep. 2020;25:100649.","journal-title":"Mol Genet Metab Rep"},{"key":"1283_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183370","volume":"12","author":"P Gehle","year":"2017","unstructured":"Gehle P, Goergen B, Pilger D, Ruokonen P, Robinson PN, Salchow DJ. Biometric and structural ocular manifestations of Marfan syndrome. PLoS ONE. 2017;12:e0183370.","journal-title":"PLoS ONE"},{"key":"1283_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ajo.2017.02.022","volume":"177","author":"M Kinori","year":"2017","unstructured":"Kinori M, Wehrli S, Kassem IS, Azar NF, Maumenee IH, Mets MB. Biometry characteristics in adults and children with Marfan syndrome: from the Marfan eye consortium of Chicago. Am J Ophthalmol. 2017;177:144\u20139.","journal-title":"Am J Ophthalmol"},{"key":"1283_CR23","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.2147\/OPTH.S269364","volume":"14","author":"R Suwal","year":"2020","unstructured":"Suwal R, Khadka S, Joshi P. Ocular manifestations and biometrics in Marfan\u2019s syndrome from eastern Nepal. Clin Ophthalmol. 2020;14:2463\u201372.","journal-title":"Clin Ophthalmol"},{"key":"1283_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mrgentox.2009.07.013","volume":"679","author":"A Sitta","year":"2009","unstructured":"Sitta A, Manfredini V, Biasi L, Trem\u00e9a R, Schwartz IV, Wajner M, et al. Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients. Mutat Res. 2009;679:13\u20136.","journal-title":"Mutat Res"},{"key":"1283_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.clinbiochem.2004.11.006","volume":"38","author":"KH Schulpis","year":"2005","unstructured":"Schulpis KH, Tsakiris S, Traeger-Synodinos J, Papassotiriou I. Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria. Clin Biochem. 2005;38:239\u201342.","journal-title":"Clin Biochem"},{"key":"1283_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ymgme.2011.03.019","volume":"103","author":"Y Sanayama","year":"2011","unstructured":"Sanayama Y, Nagasaka H, Takayanagi M, Ohura T, Sakamoto O, Ito T, et al. Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuria. Mol Genet Metab. 2011;103:220\u20135.","journal-title":"Mol Genet Metab"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-025-01283-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-025-01283-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-025-01283-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T05:40:12Z","timestamp":1776490812000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-025-01283-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1283"],"URL":"https:\/\/doi.org\/10.1007\/s10384-025-01283-3","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S. A. Seyyar, None; G. G. Soysal, None; D. Hopurcuo\u011flu, None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"In the course of preparing this manuscript, the authors utilized the QuillBot tool to enhance the language and readability, exercising caution throughout the process. Following the use of this tool, the authors carefully reviewed and revised the content as necessary, assuming full responsibility for the material presented in the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}}]}}